Today, come meet Dr. Adam Schwarz, our Chief Scientific Officer, during Qynapse’s #AI Theater Presentation at 2pm CT in the #RSNA21 AI Showcase! #rsna2021 #healthtech #digitalhealth #ai #healthcare #radiology #neuroradiology  #personalizedcare #precisionmedicine

Don’t miss your last chance to meet Qynapse on this last day of #RSNA21 Exhibition. Stop by our booth #4161 in the AI Showcase! #rsna2021 #technology #healthtech #digitalhealth #ai #healthcare #radiology #neuroradiology #neurology #imaging #biomarkers #aiinhealthcare

Lot of exciting projects and partnerships coming out from #RSNA21 this week! We look forward to continuing drive the future of #neuroimaging analysis together with #physicians on the front lines of diagnosing and treating central nervous system diseases.

Qynapse est présent aujourd'hui et demain au Congrès des Unités de soins #Alzheimer 2021 Unitesdalzheimer pour parler de nos solutions combinant l’#IRM et l’#IA pour apporter une précision et des résultats fiables au service du #diagnostic et des décisions cliniques.

Discover now Qynapse's latest publication in European Radiology 2022, presenting QyScore® performance results in comparison to a consensus of expert neuroradiologists. Link to the full article access: link.springer.com/article/10.100… #ai #neuroradiology #mri #precisionmedicine

Qynapse is thrilled to attend #ACTRIMS Forum 2022 in West Palm Beach, FL on Feb 24-26, and present new evidence on the value of QyScore® for MS #diagnosis. #ACTRIMS #actrimsforum #multiplesclerosis #MS #MSresearch #biomarkers #MRI prnewswire.com/news-releases/…

Qynapse is pleased to highlight recently published validation results for QyScore® white matter hyperintensities (WMH) segmentation in NeuroImage: Clinical. Perfect timing for #ACTRIMS next week! 👉 Link to the full article: @ doi.org/10.1016/j.nicl… #actrimsforum #MS #ai

Congratulations to @Qynapse for this new publication that brings forward the imaging biomarkers identification for small vessel disease! 👏🙌⬇️ #stroke #MRI #research #cSVD #SHiVA #biomarker

The ACTRIMS® 2022 Forum is opening today #ACTRIMS #actrimsforum! This year event themed “Biomarkers in MS”, a unique opportunity to engage with experts in #MS on the optimization of #patientmanagement and #clinicaltrials with AI-based neuroimaging #biomarkers. Meet our team!

Do not miss Adam Schwarz’s poster presentation today at #actrimsforum in Exhibit Hall A, Palm Beach County Convention Center 📍 [P152] Poster Session 1 on Feb 24 from 5:30-6:00pm Results show how QyScore® could facilitate and increase confidence in the #diagnosis and #monitoring of #MS patients.

Do not miss Adam Schwarz’s poster presentation today at #actrimsforum in Exhibit Hall A, Palm Beach County Convention Center 📍 [P251] Poster Session 2 on Feb 25 from 6:00-6:30pm Results show the high reproducibility of QyScore®’s results. #ACTRIMS #multiplesclerosis #MS #ai  #neuroradiology

Qynapse is thrilled to Qynapse to present symposium oral and poster presentations at #ADPD2022 International Conference on #Alzheimer’s and #Parkinson’s Diseases and related #neurological disorders AD/PD - Advances in Science & Therapy in Barcelona, Spain on March 15-20. prnewswire.com/news-releases/… #AI #neuro

Today at Qynapse we wanted to highlight the disproportionate impact of some major #neurological disorders on #women and acknowledge the incredible work #women do providing #care and support across these areas. linkedin.com/feed/update/ur… #InternationalWomensDay #IWD2022 #IWD22

#ADPD2022 is starting next week! Join Qynapse’s team on-site presenting a #symposium oral presentation and a #poster presentation showcasing our recent advances and evidence to our #clinicaltrials & #research solutions. #neurodegenerative #Alzheimers #parkinsons

Visit Qynapse Poster Presentation at #ADPD2022 this week presenting promising results on the reliability of our #PET pipeline for the quantification of #amyloid plaques – a key #biomarker of #alzheimersdisease. 📍On-site Poster: #P142 📍ePoster lnkd.in/eRgGsKe9 AD/PD - Advances in Science & Therapy

[DAY – 1] Tomorrow at #ADPD2022, . is hosting a symposium oral presentation focusing on the evaluation of QyPredict®, a tunable #MachineLearning #prognostic model for #Alzheimers' clinical trial enrichment #amyloid #mci #ClinicalResearch  #healthtech #digitalhealth #ai

Qynapse’s symposium oral presentation is live at #ADPD2022! QyPredict #prognostic model, shows promise in improving #clinicaltrials selection towards decliners for increased trial success probability with a single upfront screening cost. #ai #MachineLearning #Alzheimers AD/PD - Advances in Science & Therapy

Qynapse participe au congrès de la Société Française de Neuroradiologie #SFNR cette semaine à Lyon. Contactez-nous pour découvrir comment QyScore s’intègre dans la routine clinique du #radiologue apportant précision, fiabilité pour une prise de décision éclairée. #neuroscience

We’re excited to partner with Qynapse and to add advanced analysis capabilities to our full suite of proven #MedicalImaging services. Read the announcement. bit.ly/3PPoSbe #clinicaltrials #ChooseCalyx

Today, we are thrilled to announce with Calyx a groundbreaking partnership that enables AI-enhanced Medical Imaging Services for CNS Clinical Trials! Find out more about our partnership below qynapse.com/qynapse-and-ca…